Veritas Aortic Solutions

Veritas Aortic Solutions is a medical device company based in Costa Mesa, California, spun out of medical device incubator inQB8, pioneering minimally invasive transcatheter therapies for complex aortic disease. Its lead technology, the Veritas Transcatheter Valved Aortic Root Conduit (TVARC), targets the aortic root, coronary arteries and ascending aorta — among the most technically demanding and underserved areas in cardiovascular medicine — aiming to replace open-heart surgery with a non-surgical approach. The company closed a $12 million seed financing round in June 2026 to advance the technology toward clinical use.